JMB

eISSN 2093-6338

Table. 1.

Table. 1.

WBC pre-classification accuracy of the UIMD PBIA based on sample type

Sample type Sample characteristics Number of samples Cell counts Accuracy Appendix*
Total samples - 242 29,605 97.1%
Samples with NRBC Nucleated RBC ≥ 5% 60 7,568 96.3% 1–1
Samples with pancytopenia WBC < 1×109/L 20 2,481 97.7% 1–2
Samples with dysgranulopoiesis Neoplastic dysgranulopoiesis (MDS, MPN/MDS) 10 1,276 97.2% 1–3
Non-neoplastic dysgranulopoiesis (post-chemotherapy) 10 1,230 96.3% 1–4
Samples containing neutrophil precursors Neutrophil precursors < 10% 10 1,187 97.0% 1–5
Neutrophil precursors ≥ 10% 10 1,148 97.3% 1–6
Samples containing abnormal cells Myeloblasts and/or monoblasts 20 2,552 95.9% 1–7
Lymphoblasts 15 1,871 97.6% 1–8
Mature B cell neoplasm 15 1,764 97.3% 1–9
Mature T cell neoplasm 7 1,109 97.4% 1–10
Plasma cell and/or reactive lymphocytes 15 1,783 95.6% 1–11
Normal samples - 50 5,532 99.0% 1–12

*The appendix with details of the results is presented in the supplementary Table 1.

Abbreviations: NRBC, nucleated RBC; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm.

Lab Med Online 2023;13:7~12 https://doi.org/10.47429/lmo.2023.13.1.7
© Lab Med Online